AllSight
Companies · STAA · Ophthalmic Goods

STAAR SURGICAL CO (STAA)

STAAR SURGICAL CO (STAA) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

STAAR SURGICAL CO (STAA) stock — financials & valuation

Key numbers for STAAR SURGICAL CO (STAA): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 48/100 — a percentile rank of STAAR SURGICAL CO’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.

Market cap$1.1B
P / E292.3×
P / S3.3×
EV / EBITDA35.9×
Gross margin76.6%
Operating margin4.0%
Net margin1.1%
Return on equity1.1%
ROIC1.4%
Revenue growth51.3%
Debt / equity0.0×
Dividend yield0.0%

Is STAAR SURGICAL CO overvalued? P/E looks overvalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from STAAR SURGICAL CO’s own financial statements and shown as context, never as advice.

Sep 9, 2026Former CEO returns
STAAR Surgical brings back former CEO as CCO, betting on commercial reset
Aug 12, 2026Beat
The China rebound is real—but the headline growth hides a slower core
Aug 6, 2026
Performance-based option grant adds retention incentives, not operating news
Related companies in Ophthalmic Goods
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact